About the firm

Alanna Temme founded LMH Strategic Solutions and brings nearly twenty years of leadership in the life sciences industry, specialty providers, and Capitol Hill. She specializes in legislative strategy, public policy advocacy, coalition management, and corporate strategy.

Alanna previously served as a health care policy advisor to a senior member of the House Ways and Means Committee, where she built a broad bipartisan network. She has deep experience with trade associations and in coordinating strategic communications with policymakers and grassroots stakeholders. She serves as a board member and President of the Midsized Biotech Alliance of America.

Sophie has spent sixteen years shaping congressional policy, most recently as Deputy Staff Director of the House Energy and Commerce Committee under Chairman Brett Guthrie (R-KY). Before that she spent several years as his Chief of Staff, driving his agenda, leading the team, and delivering results on major policy priorities. She brings that expertise, her relationships across the Hill, and a proven record to LMH's clients.

Max works with biotechnology and pharmaceutical clients on market access and regulatory issues. Much of his work is turning clinical data into policy arguments that hold up on Capitol Hill, so a new technology’s value is clear to the members and staff who shape the policy around it.

Before joining LMH, Max was a research engineer in spatial biology and implantable neurotechnology. He holds an M.S. in Bioengineering from the University of Washington, so he can read the science behind a client's product as closely as the policy around it.

Amy Efantis is an advisor to LMH Strategic Solutions, focused on the Midsized Biotech Alliance of America. She brings more than two decades of government affairs leadership in Washington, D.C. and abroad, including leading organizations, serving on boards, and developing teams.

Amy was a health care policy advisor on the Energy and Commerce Committee for Congressman Tom Barrett (D-WI) and Legislative Director for Ways and Means Committee member Congressman Artur Davis (D-AL), and built a strong bipartisan network on Capitol Hill. She has worked in and led trade associations and coalitions in the life sciences. She serves on the board of Patients Rising and previously served on the board of the Alliance for Aging Research.

Jake works with biotechnology and pharmaceutical clients on the legislative and regulatory issues shaping the life sciences sector. He tracks policy developments, assesses what they mean for each client's priorities, and builds the engagement strategy that follows.

Before joining LMH, Jake worked in finance. He holds a B.A. in Economics with a second major in Finance from Washington University in St. Louis, and he applies that training to forecasting how policy decisions move drug development and pricing.

Before joining LMH, Olivia graduated from the University of Georgia with degrees in Agricultural and Applied Economics and Agribusiness, along with a minor in Law, Jurisprudence, and the State. She draws on her interdisciplinary background in economics, business, and legal studies to understand how policy decisions and government affairs shape the healthcare industry and the companies operating within it.